Evidence-Based Dermatology: Research Commentary
Feb 2012

Randomized Controlled Trials Needed for Bullous Pemphigoid Interventions

Arch Dermatol. 2012;148(2):243-246. doi:10.1001/archdermatol.2011.826

Commentary on: Interventions for Bullous Pemphigoid Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP Cochrane Database Syst Rev. 2010 Oct 6;(10):CD002292

Background: Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the West. Oral steroids are the standard treatment. This is an update of the review published in 2005.

Objectives: To assess treatments for bullous pemphigoid.

First Page Preview View Large
First page PDF preview
First page PDF preview